engleski

The COVID-19 pandemic and the silent epidemic of sarcopenia

The term sarcopenia is defined as age-related loss of muscle mass and function. The SARS-CoV-2 virus causes direct changes in muscle tissue. Restrictive measures were introduced, leading to increased stress and changes in diet, and normal lifestyle. The first goal of this paper is to estimate the incidence of secondary sarcopenia during the COVID-19 pandemic. The second goal is to summarize possible measures to prevent the occurrence of sarcopenia. Available studies on the COVID-19 pandemic that prove negative effects on muscle strength and mass were analyzed. Recommended measures have been registered, which refer to the possibility of daily physical activity, dietary characteristics, stress control and the possibility of using vitamin and mineral supplements that significantly affect the health of an individual. 20 studies related to the link between the COVID- 19 pandemic and the occurrence of sarcopenia were reviewed. All relevant studies indicate an increased incidence of sarcopenia during the COVID-19 pandemic, which can also be considered a silent epidemic. The proposed measures can benefit nutritionists and other multidisciplinary teams dealing with the prevention and treatment of COVID-19 and the negative consequences. Due to the epidemic phenomenon of sarcopenia, preventive nutritional interventions are of special importance.

sarcopenia ; COVID-19 ; isolation ; stress ; nutritional interventions

nije evidentirano